The Exenatide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Exenatide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Exenatide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Extended-release injectable suspension segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Exenatide include AstraZeneca, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Exenatide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Extended-release injectable suspension
Fast release injectable suspension
Market segment by Application, can be divided into
Hospital
Drug store
Market segment by players, this report covers
AstraZeneca
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Exenatide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Exenatide, with revenue, gross margin and global market share of Exenatide from 2019 to 2022.
Chapter 3, the Exenatide competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Exenatide market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Exenatide research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Exenatide
1.2 Classification of Exenatide by Type
1.2.1 Overview: Global Exenatide Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Exenatide Revenue Market Share by Type in 2021
1.2.3 Extended-release injectable suspension
1.2.4 Fast release injectable suspension
1.3 Global Exenatide Market by Application
1.3.1 Overview: Global Exenatide Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Exenatide Market Size & Forecast
1.5 Global Exenatide Market Size and Forecast by Region
1.5.1 Global Exenatide Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Exenatide Market Size by Region, (2017-2022)
1.5.3 North America Exenatide Market Size and Prospect (2017-2028)
1.5.4 Europe Exenatide Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Exenatide Market Size and Prospect (2017-2028)
1.5.6 South America Exenatide Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Exenatide Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Exenatide Market Drivers
1.6.2 Exenatide Market Restraints
1.6.3 Exenatide Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Exenatide Product and Solutions
2.1.4 AstraZeneca Exenatide Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AstraZeneca Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Exenatide Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Exenatide Players Market Share in 2021
3.2.2 Top 10 Exenatide Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Exenatide Players Head Office, Products and Services Provided
3.4 Exenatide Mergers & Acquisitions
3.5 Exenatide New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Exenatide Revenue and Market Share by Type (2017-2022)
4.2 Global Exenatide Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Exenatide Revenue Market Share by Application (2017-2022)
5.2 Global Exenatide Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Exenatide Revenue by Type (2017-2028)
6.2 North America Exenatide Revenue by Application (2017-2028)
6.3 North America Exenatide Market Size by Country
6.3.1 North America Exenatide Revenue by Country (2017-2028)
6.3.2 United States Exenatide Market Size and Forecast (2017-2028)
6.3.3 Canada Exenatide Market Size and Forecast (2017-2028)
6.3.4 Mexico Exenatide Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Exenatide Revenue by Type (2017-2028)
7.2 Europe Exenatide Revenue by Application (2017-2028)
7.3 Europe Exenatide Market Size by Country
7.3.1 Europe Exenatide Revenue by Country (2017-2028)
7.3.2 Germany Exenatide Market Size and Forecast (2017-2028)
7.3.3 France Exenatide Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Exenatide Market Size and Forecast (2017-2028)
7.3.5 Russia Exenatide Market Size and Forecast (2017-2028)
7.3.6 Italy Exenatide Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Exenatide Revenue by Type (2017-2028)
8.2 Asia-Pacific Exenatide Revenue by Application (2017-2028)
8.3 Asia-Pacific Exenatide Market Size by Region
8.3.1 Asia-Pacific Exenatide Revenue by Region (2017-2028)
8.3.2 China Exenatide Market Size and Forecast (2017-2028)
8.3.3 Japan Exenatide Market Size and Forecast (2017-2028)
8.3.4 South Korea Exenatide Market Size and Forecast (2017-2028)
8.3.5 India Exenatide Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Exenatide Market Size and Forecast (2017-2028)
8.3.7 Australia Exenatide Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Exenatide Revenue by Type (2017-2028)
9.2 South America Exenatide Revenue by Application (2017-2028)
9.3 South America Exenatide Market Size by Country
9.3.1 South America Exenatide Revenue by Country (2017-2028)
9.3.2 Brazil Exenatide Market Size and Forecast (2017-2028)
9.3.3 Argentina Exenatide Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Exenatide Revenue by Type (2017-2028)
10.2 Middle East & Africa Exenatide Revenue by Application (2017-2028)
10.3 Middle East & Africa Exenatide Market Size by Country
10.3.1 Middle East & Africa Exenatide Revenue by Country (2017-2028)
10.3.2 Turkey Exenatide Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Exenatide Market Size and Forecast (2017-2028)
10.3.4 UAE Exenatide Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Exenatide Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Exenatide Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Exenatide Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Exenatide Revenue (USD Million) by Region (2017-2022)
Table 5. Global Exenatide Revenue Market Share by Region (2023-2028)
Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Exenatide Product and Solutions
Table 9. AstraZeneca Exenatide Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Global Exenatide Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 11. Global Exenatide Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 12. Breakdown of Exenatide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Exenatide Players Head Office, Products and Services Provided
Table 14. Exenatide Mergers & Acquisitions in the Past Five Years
Table 15. Exenatide New Entrants and Expansion Plans
Table 16. Global Exenatide Revenue (USD Million) by Type (2017-2022)
Table 17. Global Exenatide Revenue Share by Type (2017-2022)
Table 18. Global Exenatide Revenue Forecast by Type (2023-2028)
Table 19. Global Exenatide Revenue by Application (2017-2022)
Table 20. Global Exenatide Revenue Forecast by Application (2023-2028)
Table 21. North America Exenatide Revenue by Type (2017-2022) & (USD Million)
Table 22. North America Exenatide Revenue by Type (2023-2028) & (USD Million)
Table 23. North America Exenatide Revenue by Application (2017-2022) & (USD Million)
Table 24. North America Exenatide Revenue by Application (2023-2028) & (USD Million)
Table 25. North America Exenatide Revenue by Country (2017-2022) & (USD Million)
Table 26. North America Exenatide Revenue by Country (2023-2028) & (USD Million)
Table 27. Europe Exenatide Revenue by Type (2017-2022) & (USD Million)
Table 28. Europe Exenatide Revenue by Type (2023-2028) & (USD Million)
Table 29. Europe Exenatide Revenue by Application (2017-2022) & (USD Million)
Table 30. Europe Exenatide Revenue by Application (2023-2028) & (USD Million)
Table 31. Europe Exenatide Revenue by Country (2017-2022) & (USD Million)
Table 32. Europe Exenatide Revenue by Country (2023-2028) & (USD Million)
Table 33. Asia-Pacific Exenatide Revenue by Type (2017-2022) & (USD Million)
Table 34. Asia-Pacific Exenatide Revenue by Type (2023-2028) & (USD Million)
Table 35. Asia-Pacific Exenatide Revenue by Application (2017-2022) & (USD Million)
Table 36. Asia-Pacific Exenatide Revenue by Application (2023-2028) & (USD Million)
Table 37. Asia-Pacific Exenatide Revenue by Region (2017-2022) & (USD Million)
Table 38. Asia-Pacific Exenatide Revenue by Region (2023-2028) & (USD Million)
Table 39. South America Exenatide Revenue by Type (2017-2022) & (USD Million)
Table 40. South America Exenatide Revenue by Type (2023-2028) & (USD Million)
Table 41. South America Exenatide Revenue by Application (2017-2022) & (USD Million)
Table 42. South America Exenatide Revenue by Application (2023-2028) & (USD Million)
Table 43. South America Exenatide Revenue by Country (2017-2022) & (USD Million)
Table 44. South America Exenatide Revenue by Country (2023-2028) & (USD Million)
Table 45. Middle East & Africa Exenatide Revenue by Type (2017-2022) & (USD Million)
Table 46. Middle East & Africa Exenatide Revenue by Type (2023-2028) & (USD Million)
Table 47. Middle East & Africa Exenatide Revenue by Application (2017-2022) & (USD Million)
Table 48. Middle East & Africa Exenatide Revenue by Application (2023-2028) & (USD Million)
Table 49. Middle East & Africa Exenatide Revenue by Country (2017-2022) & (USD Million)
Table 50. Middle East & Africa Exenatide Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Exenatide Picture
Figure 2. Global Exenatide Revenue Market Share by Type in 2021
Figure 3. Extended-release injectable suspension
Figure 4. Fast release injectable suspension
Figure 5. Exenatide Revenue Market Share by Application in 2021
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Exenatide Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Exenatide Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Exenatide Revenue Market Share by Region (2017-2028)
Figure 11. Global Exenatide Revenue Market Share by Region in 2021
Figure 12. North America Exenatide Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Exenatide Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Exenatide Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Exenatide Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Exenatide Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Exenatide Market Drivers
Figure 18. Exenatide Market Restraints
Figure 19. Exenatide Market Trends
Figure 20. AstraZeneca Recent Developments and Future Plans
Figure 21. Global Exenatide Revenue Share by Players in 2021
Figure 22. Exenatide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 23. Global Top 3 Players Exenatide Revenue Market Share in 2021
Figure 24. Global Top 10 Players Exenatide Revenue Market Share in 2021
Figure 25. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 26. Global Exenatide Revenue Share by Type in 2021
Figure 27. Global Exenatide Market Share Forecast by Type (2023-2028)
Figure 28. Global Exenatide Revenue Share by Application in 2021
Figure 29. Global Exenatide Market Share Forecast by Application (2023-2028)
Figure 30. North America Exenatide Sales Market Share by Type (2017-2028)
Figure 31. North America Exenatide Sales Market Share by Application (2017-2028)
Figure 32. North America Exenatide Revenue Market Share by Country (2017-2028)
Figure 33. United States Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 34. Canada Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 35. Mexico Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 36. Europe Exenatide Sales Market Share by Type (2017-2028)
Figure 37. Europe Exenatide Sales Market Share by Application (2017-2028)
Figure 38. Europe Exenatide Revenue Market Share by Country (2017-2028)
Figure 39. Germany Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. France Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. United Kingdom Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Russia Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Italy Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Asia-Pacific Exenatide Sales Market Share by Type (2017-2028)
Figure 45. Asia-Pacific Exenatide Sales Market Share by Application (2017-2028)
Figure 46. Asia-Pacific Exenatide Revenue Market Share by Region (2017-2028)
Figure 47. China Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Japan Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. South Korea Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. India Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Southeast Asia Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Australia Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. South America Exenatide Sales Market Share by Type (2017-2028)
Figure 54. South America Exenatide Sales Market Share by Application (2017-2028)
Figure 55. South America Exenatide Revenue Market Share by Country (2017-2028)
Figure 56. Brazil Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Argentina Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Middle East and Africa Exenatide Sales Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Exenatide Sales Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Exenatide Revenue Market Share by Country (2017-2028)
Figure 61. Turkey Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Saudi Arabia Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. UAE Exenatide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Methodology
Figure 65. Research Process and Data Source